Published data demonstrates that 3 out of 10 people are not receiving the full benefits of their aspirin therapy.

The Issue
Platelet-mediated thrombus can lead to a heart attack, stroke, or other vascular event. Over 20 million people in the U.S. take aspirin daily to prevent platelets from clotting. Clinical data shows that not all patients receive the full benefits of aspirin, therefore it is important to ensure that your patients are receiving the expected anti-platelet benefits.

The Solution
The Ultegra System is a useful tool to aid in the detection of platelet dysfunction due to aspirin ingestion. It can help ensure that your patients have received the expected benefits of aspirin. Make more informed decisions about the therapy of your patients.

• Rapid results in less than 10 minutes
• Whole blood sample, requires no preparation
• Room temperature stability of reagents requires no special storage
• Automatic sampling from closed tube, no blood exposure to operator

BACK TO INSTRUMENTS